{"id":17294,"date":"2026-08-21T17:08:08","date_gmt":"2026-08-21T15:08:08","guid":{"rendered":"https:\/\/www.interpharma.ch\/?p=17294"},"modified":"2026-08-21T17:37:29","modified_gmt":"2026-08-21T15:37:29","slug":"communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/","title":{"rendered":"Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse"},"content":{"rendered":"\n<p><strong>La Commission de la s\u00e9curit\u00e9 sociale et de la sant\u00e9 publique du Conseil national a \u00e9mis un signal important pour les patientes et patients de Suisse: vu les difficult\u00e9s croissantes d\u2019acc\u00e8s aux traitements innovants et les modifications des conditions cadres internationales, elle rejette la mise en \u0153uvre de la r\u00e9vision de l\u2019OAMal sous la forme actuelle.<\/strong><\/p>\n\n\n\n<p>La d\u00e9cision prise aujourd\u2019hui par Commission de la s\u00e9curit\u00e9 sociale et de la sant\u00e9 publique du Conseil national (CSSS-N) est un signal important pour les patient-e-s de Suisse: vu la d\u00e9gradation croissante de l\u2019acc\u00e8s aux traitements innovants, il est r\u00e9jouissant que la Commission tienne compte des modifications des conditions cadres internationales et rejette une mise en \u0153uvre pr\u00e9cipit\u00e9e de la r\u00e9vision de l\u2019OAMal.<\/p>\n\n\n\n<p>La version actuelle du projet porte trop unilat\u00e9ralement sur la ma\u00eetrise des co\u00fbts et omet d\u2019aborder la d\u00e9gradation constante de l\u2019acc\u00e8s aux traitements innovants en Suisse. En m\u00eame temps, elle ignore les modifications des conditions cadres internationales. L\u2019introduction d\u2019un syst\u00e8me de prix de r\u00e9f\u00e9rence aux \u00c9tats-Unis accro\u00eet la pression sur la formation des prix et donc aussi sur la disponibilit\u00e9 des m\u00e9dicaments innovants dans les pays de r\u00e9f\u00e9rence, dont \u00e9galement la Suisse. Une enqu\u00eate actuelle d\u2019Interpharma montre que les cons\u00e9quences se font d\u00e9j\u00e0 sentir: c\u2019est ainsi qu\u2019afin d\u2019\u00e9viter des baisses de prix aux \u00c9tats-Unis, environ un nouveau m\u00e9dicament innovant sur trois n\u2019est plus soumis \u00e0 la prise en charge par les caisses-maladie.<\/p>\n\n\n\n<p>La Commission de la s\u00e9curit\u00e9 sociale et de la sant\u00e9 publique du Conseil des \u00c9tats (CSSS-E) a \u00e0 pr\u00e9sent l\u2019opportunit\u00e9 de proposer une r\u00e9orientation strat\u00e9gique du projet, de mani\u00e8re \u00e0 harmoniser \u00e0 long terme la ma\u00eetrise des co\u00fbts, l\u2019acc\u00e8s rapide des patient-e-s et le renforcement de la place des sciences de la vie qu\u2019est la Suisse.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Commission de la s\u00e9curit\u00e9 sociale et de la sant\u00e9 publique du Conseil national a \u00e9mis un signal important pour les patientes et patients de Suisse: vu les difficult\u00e9s croissantes d\u2019acc\u00e8s aux traitements innovants et les modifications des conditions cadres internationales, elle rejette la mise en \u0153uvre de la r\u00e9vision de l\u2019OAMal sous la forme [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":14216,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[127,138,140],"class_list":["post-17294","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-acces-des-patients","tag-parlement","tag-acces-a-linnovation"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse\" \/>\n<meta property=\"og:description\" content=\"La Commission de la s\u00e9curit\u00e9 sociale et de la sant\u00e9 publique du Conseil national a \u00e9mis un signal important pour les patientes et patients de Suisse: vu les difficult\u00e9s croissantes d\u2019acc\u00e8s aux traitements innovants et les modifications des conditions cadres internationales, elle rejette la mise en \u0153uvre de la r\u00e9vision de l\u2019OAMal sous la forme [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-21T15:08:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-21T15:37:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/02\/blog-image-030-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lukaskuemmerli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"lukaskuemmerli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/\"},\"author\":{\"name\":\"lukaskuemmerli\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/2854d813965ba4a7feaeffbe96f8eadf\"},\"headline\":\"Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse\",\"datePublished\":\"2026-08-21T15:08:08+00:00\",\"dateModified\":\"2026-08-21T15:37:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/\"},\"wordCount\":350,\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/blog-image-030-scaled.jpeg\",\"keywords\":[\"Acc\u00e8s des patients\",\"Parlement\",\"acc\u00e8s \u00e0 l'innovation\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/\",\"name\":\"Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse - Interpharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/blog-image-030-scaled.jpeg\",\"datePublished\":\"2026-08-21T15:08:08+00:00\",\"dateModified\":\"2026-08-21T15:37:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/blog-image-030-scaled.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/blog-image-030-scaled.jpeg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.interpharma.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\\\/\\\/interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/interpharma_ch\",\"https:\\\/\\\/ch.linkedin.com\\\/company\\\/interpharma\",\"https:\\\/\\\/www.instagram.com\\\/interpharma_ch\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/2854d813965ba4a7feaeffbe96f8eadf\",\"name\":\"lukaskuemmerli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"caption\":\"lukaskuemmerli\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse","og_description":"La Commission de la s\u00e9curit\u00e9 sociale et de la sant\u00e9 publique du Conseil national a \u00e9mis un signal important pour les patientes et patients de Suisse: vu les difficult\u00e9s croissantes d\u2019acc\u00e8s aux traitements innovants et les modifications des conditions cadres internationales, elle rejette la mise en \u0153uvre de la r\u00e9vision de l\u2019OAMal sous la forme [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/","og_site_name":"Interpharma","article_published_time":"2026-08-21T15:08:08+00:00","article_modified_time":"2026-08-21T15:37:29+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/02\/blog-image-030-scaled.jpeg","type":"image\/jpeg"}],"author":"lukaskuemmerli","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"lukaskuemmerli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/"},"author":{"name":"lukaskuemmerli","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf"},"headline":"Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse","datePublished":"2026-08-21T15:08:08+00:00","dateModified":"2026-08-21T15:37:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/"},"wordCount":350,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/02\/blog-image-030-scaled.jpeg","keywords":["Acc\u00e8s des patients","Parlement","acc\u00e8s \u00e0 l'innovation"],"inLanguage":"fr-FR","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/","name":"Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/02\/blog-image-030-scaled.jpeg","datePublished":"2026-08-21T15:08:08+00:00","dateModified":"2026-08-21T15:37:29+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/02\/blog-image-030-scaled.jpeg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/02\/blog-image-030-scaled.jpeg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-un-signal-important-pour-les-patientes-et-patients-de-suisse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: Un signal important pour les patientes et patients de Suisse"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf","name":"lukaskuemmerli","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","caption":"lukaskuemmerli"}}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/17294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=17294"}],"version-history":[{"count":2,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/17294\/revisions"}],"predecessor-version":[{"id":17296,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/17294\/revisions\/17296"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/14216"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=17294"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=17294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}